Pulse Biosciences Inc(PLSE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 4:41 PM ET (Korea 10/28 05:41)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.17 | Insider Own | 69.7% | Shs Outstand | 70.8M | Perf Week | 4.64% |
| Market Cap | 3.87B | Forward P/E | - | EPS next Y | -5.5% | Insider Trans | 1.36% | Shs Float | 22.0M | Perf Month | 1.68% |
| Enterprise Value | 3.77B | PEG | - | EPS next Q | -0.31 | Inst Own | 14.78% | Short Float | 13.64% | Perf Quarter | 55.33% |
| Income | -0.08B | P/S | 3250.23 | EPS this Y | -57.24% | Inst Trans | 31.46% | Short Ratio | 5.84 | Perf Half Y | 143.7% |
| Sales | 0.00B | P/B | 37.85 | EPS next 5Y | -12.34% | ROA | -67.9% | Short Interest | 3.00M | Perf YTD | 287.47% |
| Book/sh | 1.41 | P/C | 38.06 | EPS past 3/5Y | 14.44% 12.82% | ROE | -78.49% | 52W High | -9.68% ($58.90) | Perf Year | 204% |
| Cash/sh | 1.4 | P/FCF | - | Sales past 3/5Y | -20.63% - | ROIC | -76.55% | 52W Low | 323.57% ($12.56) | Perf 3Y | 1175.78% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -11.31% | Gross Margin | -43.21% | Volatility(W/M) | 4.71% 6.58% | Perf 5Y | 159.01% |
| Dividend TTM | - | EV/Sales | 3170.53 | Sales Y/Y TTM | - | Oper. Margin | -7007.76% | ATR (14) | 3.2 | Perf 10Y | 794.12% |
| Dividend Ex-Date | - | Quick Ratio | 9.61 | EPS Q/Q | -25.06% | Profit Margin | -6755.78% | RSI (14) | 57.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.63 | Sales Q/Q | - | SMA20 | 6.47% ($49.97) | Beta | 1.66 | Target Price | $62.33 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2026/11/5 | SMA50 | 4.99% ($50.67) | Rel Volume | 0.64 | Prev Close | $52.66 |
| Employees | 116 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 8.23% -13.2% | SMA200 | 72.97% ($30.76) | Avg Volume(3M) | 0.51M | Price | $53.2 |
| IPO | 2016/5/18 | Option/Short | Yes/Yes | Trades | 5080 | Volume | 328,970 | Change | 1.03% |
⚡ A U.S. medical device company developing equipment that leverages nanosecond pulsed electric field (nsPEF) technology. Using its proprietary technology that eliminates targeted cells through brief electrical pulses, the company develops medical devices aimed at treating cardiac arrhythmias and skin conditions, and is pushing toward commercialization. As a developer of medical devices built around the differentiated nsPEF technology, the stock's performance hinges heavily on progress in clinical trials and commercialization milestones.
Over the past 1 year, on the higher side
10% below its 1-year high.
Traded less than usual. That is 64% of its average volume.
Next earnings report: November 5
8 days to go.
PLSE has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -57.2% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $325,023. Peers typically go for $272.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +159.0%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 14.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #20 of 51 in the industry
Based on market cap of $4B.
ICUI#19 ICU Medical Inc $4B PER 137.9 PLSE#20 Pulse Biosciences Inc $4B PER - 
NVST#21 Envista Holdings Corp $4B PER 41.0 
ATRC#22 Atricure Inc $3B PER 284.1 
WRBY#23 Warby Parker Inc $3B PER 413.0 
FAQ
What kind of company is PLSE?
PLSE belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of PLSE?
The market cap of PLSE is approximately $3.9B, ranking 1,566 within its sector.
What is the 52-week high and low for PLSE?
PLSE has recorded a 52-week high of $58.90 and a low of $12.56.
